Imagine a street in the Netherlands in which all the leading companies in the field of regenerative medicine are based. Impossible?
Right now, the first steps are being taken on the Chemelot Campus towards a so-called 'Regeneration Street'.
Regenerative medicine is a totally new branch of medicine and healthcare that focuses on regenerating – or replacing – cells and tissues. You might compare it with the worm that repairs itself after a piece has been chopped off. Or a cutting from a plant, from which an entirely new plant can grow. Regenerative medicine is about people, and allows treatment of a variety of complaints. Examples include broken bones, damaged jaws and – who knows? – perhaps even complete organs in the future. The plan is for production companies, research institutes and contract production companies active in regenerative medicine and tissue engineering to move in next to each other on Chemelot Campus.
The first building in the street has now been completed. Regeneration Street no.1 has a floor area of 2,400 m2 with 750 m2 of clean-room facilities that will be extended to 650 m2 in 2014. The ambition is to make capacity of 50,000 m2 available by 2023. PharmaCell is playing a major role in the realisation of Regeneration Street no.1, where the company is renting facilities for large-scale contract production and is also helping other tenants to start production.
Another part of the building is available for the Chemelot Institute for Science and Technology, Chemelot InSciTe. This is a research and knowledge institute for bio-based and biomedical materials.